Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126183651 | 12618365 | 1 | I | 20160504 | 20160803 | 20160803 | PER | US-PFIZER INC-2016246504 | PFIZER | 66.00 | YR | F | Y | 0.00000 | 20160803 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126183651 | 12618365 | 1 | PS | AROMASIN | EXEMESTANE | 1 | 25 MG, 1X/DAY | U | 20753 | 25 | MG | COATED TABLET | QD | ||||||
126183651 | 12618365 | 2 | SS | AROMASIN | EXEMESTANE | 1 | U | 20753 | COATED TABLET | ||||||||||
126183651 | 12618365 | 3 | SS | AROMASIN | EXEMESTANE | 1 | U | 20753 | COATED TABLET | ||||||||||
126183651 | 12618365 | 4 | SS | AROMASIN | EXEMESTANE | 1 | U | 20753 | COATED TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126183651 | 12618365 | 1 | Breast cancer metastatic |
126183651 | 12618365 | 2 | Breast cancer female |
126183651 | 12618365 | 3 | Adrenal gland cancer |
126183651 | 12618365 | 4 | Lung neoplasm malignant |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126183651 | 12618365 | Breast cancer metastatic | |
126183651 | 12618365 | Disease progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |